| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Naringenin | Dyslipidemia | 1 | PM | 35354142 | 📋 | Naringenin alleviates obesity-associated hypertension by reducing hyperlipidemia and oxidative stress |
| Naringenin | Hypercholesterolemia | 2 | PM | 36555447 | 📋 | Mechanism Underlying Naringenin Hypocholesterolemic Effects: Involvement of Estrogen Receptor α Subtype |
| Naringenin | Hypercholesterolemia | 1 | PM | 20567977 | 📋 | Dietary naringenin increases hepatic peroxisome proliferators-activated receptor α protein expression and decreases plasma triglyceride and adiposity in rats |
| Naringenin | Hyperlipidemia | 2 | PM | 35189328 | 📋 | Beneficial Effects of Citrus Flavanones Naringin and Naringenin and Their Food Sources on Lipid Metabolism: An Update on Bioavailability, Pharmacokinetics, and Mechanisms |
| Naringenin | Hyperlipidemia | 1 | PM | 34860705 | 📋 | Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial |
